Syringes and a field of Johnson & Johnson vaccine.
Paul Hennessy | SOPA Photographs | LightRocket | Getty Photographs
The one Johnson & Johnson facility at the moment making usable batches of the corporate’s single-shot coronavirus vaccine has quickly halted its manufacturing, a new report said Tuesday.
The Netherlands-based plant has as an alternative centered on making a distinct, presumably extra worthwhile vaccine geared toward a distinct virus, The New York Instances reported, citing folks conversant in the matter.
The pause in manufacturing on the Leiden facility, which started late final 12 months and is predicted to final just a few months, might cut back the availability of J&J’s Covid vaccine by a whole lot of tens of millions of doses, a kind of folks advised the Instances.
It’s unclear whether or not vaccine provides have been been affected by the corporate’s transfer, based on the report. J&J is making ready to have the Leiden plant restart Covid vaccine manufacturing in March, the Instances reported.
J&J spokesman Jake Sargent did not straight touch upon the Instances’ article. He advised CNBC in an announcement the corporate is “centered on guaranteeing our vaccine is obtainable the place persons are in want,” and that it’s fulfilling its obligations to the worldwide teams attempting to spice up Covid vaccine entry.
J&J is constant to ship batches of the vaccine supplies to websites that bottle and package deal doses, and “we at the moment have tens of millions of doses of our Covid-19 vaccine in stock,” Sargent mentioned.
“We’re happy with the work of our many trade companions and the collaborations we have now developed to supply our COVID-19 vaccine,” he mentioned.
Polls show that many Individuals have taken a skeptical eye towards J&J Covid vaccine, which is the only one approved by the U.S. Meals and Drug Administration that requires only a single shot as a main dose, versus the two-dose routine of vaccines produced by Pfizer and Moderna.
The FDA final 12 months recommended pausing the use of the J&J vaccine following a small variety of reviews of recipients creating uncommon blood clots. It was additionally discovered to be less effective against the deadly delta variant that emerged final 12 months.
However a number of research have proven the shot remains effective at preventing hospitalization and death from Covid, and a booster dose has been shown effective in protecting in opposition to extreme sickness from the extremely transmissible omicron variant.
The J&J vaccine can be simpler to move and distribute, owing to the truth that it requires only one dose and may be saved with no freezer, growing entry to individuals who could in any other case be unable to get totally vaccinated.